Newport Beach, California (PRWEB) April 10, 2013
Vestiage, Inc., an anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium branded highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it has filed a disclosure statement known as Form 15c2-11 with the OTC Markets Exchange. The release outlines Company details for the first time to the public and clears the path for a symbol change application in the upcoming month.
“We are pleased to have executed this component of our plan to increase the visibility of the Company with market participants," stated Scott Kimball, CEO of Vestiage, Inc. "The Company is now public and we have several initiatives to execute upon in the coming months and years, including our acquisition program, expansion of distribution in multiple channels for our brands, and the beginning of our investor relations campaign. Our investor relations efforts will begin to show the investment community the power of the model we have created, the power of the team we have assembled, and the synergies of the acquisitions we are pursuing. We intend to acquire brands and integrate and leverage their management teams expertise into our business, add key advisory board members that can have true impact on our business, and grow our footprint geographically through online, direct response, and retail depending upon the brand."
The disclosure filing describes the Company's securities, the number and class of shares outstanding, names the Company's law firm and transfer agent, discusses the Company's business strategy and names the Company's Directors and Executive Officers as well as certain beneficial owners of the Company stock.
Copyright©2012 Vocus, Inc.
All rights reserved